| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.298 | 32.009 | 29.414 | 55.926 | 69.988 | 77.426 | 79.296 | 98.716 |
| Total Income - EUR | - | - | 12.889 | 34.330 | 30.931 | 57.927 | 69.988 | 77.426 | 79.300 | 99.154 |
| Total Expenses - EUR | - | - | 1.657 | 6.141 | 4.054 | 546 | 10.715 | 11.089 | 18.487 | 27.501 |
| Gross Profit/Loss - EUR | - | - | 11.232 | 28.189 | 26.877 | 57.381 | 59.273 | 66.337 | 60.813 | 71.653 |
| Net Profit/Loss - EUR | - | - | 11.003 | 27.869 | 26.174 | 55.818 | 57.635 | 64.584 | 60.115 | 68.738 |
| Employees | - | - | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endomediab Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 559 | 379 | 207 | 40 | 0 | 0 | 3.268 |
| Current Assets | - | - | 11.534 | 38.624 | 42.986 | 58.065 | 58.427 | 74.364 | 78.531 | 67.165 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 192 | 387 | 2.962 | 3.428 | 1.304 | 51.774 | 46.890 | 48.461 |
| Cash | - | - | 11.341 | 38.238 | 40.024 | 54.637 | 57.124 | 22.590 | 31.641 | 18.703 |
| Shareholders Funds | - | - | 11.046 | 38.713 | 43.065 | 56.719 | 57.837 | 64.647 | 60.699 | 68.787 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 487 | 470 | 301 | 1.553 | 631 | 9.717 | 17.832 | 1.645 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomediab Medical Srl